Konstantin Dragnev: Clinical Trials

2 trials sponsored by Konstantin Dragnev, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 11Terminated 1

Follow Konstantin Dragnev: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer
erlotinib and bexarotene - Carcinoma, Non-small-cell Lung
Phase 2CompletedKonstantin Dragnev422005-08-012019-01-08
Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer
ABT-751 and Carboplatin - Non Small Cell Lung Cancer, Lung Cancer
Phase 1 / Phase 2TerminatedKonstantin Dragnev202004-09-012018-10-12

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma (1)  ·  Lung Neoplasms (1)

Interventions

ABT751 (1)  ·  Bexarotene (1)  ·  Carboplatin (1)  ·  Erlotinib Hydrochloride (1)

Countries

United States (2)

Top investigators

Konstantin H Dragnev, MD (2)

Results publications

PMID 23147218